We are live on ! Find out more
KMC

Kirr Marbach & Co Portfolio holdings

AUM $594M
1-Year Est. Return 34%
This Fund
S&P 500
This Quarter Est. Return
+7.46%
1 Year Est. Return
+34%
3 Year Est. Return
+134.53%
5 Year Est. Return
+183.29%
10 Year Est. Return
+532.35%
AUM
$549M
AUM Growth
+$25.6M
Cap. Flow
+$8.96M
Cap. Flow %
1.63%
Top 10 Hldgs %
48.94%
Holding
61
New
3
Increased
32
Reduced
12
Closed
4

Top Sells

Rank Stock Value
1
VLTO icon
Veralto
VLTO
+$8.4M
2
DIS icon
Walt Disney
DIS
+$3.88M
3
RXO icon
RXO
RXO
+$2.17M
4
MTZ icon
MasTec
MTZ
+$1.99M
5
EME icon
Emcor
EME
+$1.43M

Sector Composition

Rank Sector Weight
1 Industrials 35.94%
2 Consumer Discretionary 8%
3 Technology 7.68%
4 Communication Services 6.85%
5 Financials 5.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
51
Apple
AAPL
$4.54T
$399K 0.07%
1,572
SKWD icon
52
Skyward Specialty Insurance
SKWD
$2.43B
$384K 0.07%
8,786
RSP icon
53
Invesco S&P 500 Equal Weight ETF
RSP
$97B
$345K 0.06%
1,799
+49
+3% +$9.71K
CAT icon
54
Caterpillar
CAT
$375B
$312K 0.06%
440
HD icon
55
Home Depot
HD
$331B
$278K 0.05%
844
ABBV icon
56
AbbVie
ABBV
$443B
$273K 0.05%
1,255
AMZN icon
57
Amazon
AMZN
$2.92T
$241K 0.04%
1,159
+59
+5% +$13K
DIS icon
58
Walt Disney
DIS
$167B
-33,965
Closed -$3.88M
MSFT icon
59
Microsoft
MSFT
$3.45T
-435
Closed -$210K
RXO icon
60
RXO
RXO
$3.34B
-171,884
Closed -$2.17M
VLTO icon
61
Veralto
VLTO
$23B
-84,028
Closed -$8.4M

Similar funds

Kirr Marbach & Co's Q1 2026 Portfolio in Review

As of Q1 2026, Kirr Marbach & Co held 61 positions worth $549M, up 4.9% from $523M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Kirr Marbach & Co's Q1 2026 filing shows 3 new, 32 increased, 12 reduced and 4 closed positions. Its largest new stake was Royalty Pharma: 237,895 shares worth $11.4M. The largest sale was Veralto, an estimated $8.4M.

By sector, the portfolio is most concentrated in Industrials at 36% of assets, up from 33% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Kirr Marbach & Co's largest Q1 2026 buy was Royalty Pharma: 237,895 shares worth $11.4M.
  • Kirr Marbach & Co added most to ICU Medical in Q1 2026, an estimated $987K increase.
  • Kirr Marbach & Co's biggest Q1 2026 reduction was MasTec, cutting an estimated $1.99M.
  • Kirr Marbach & Co fully exited Veralto in Q1 2026, selling an estimated $8.4M.
  • Kirr Marbach & Co's ten largest holdings make up 49% of its $549M portfolio in Q1 2026.
  • Kirr Marbach & Co opened 3 new positions and closed 4 in Q1 2026.
  • Kirr Marbach & Co's portfolio value rose 4.9% quarter-over-quarter to $549M.

Based on Kirr Marbach & Co's 13F filing for Q1 2026, filed 17 Apr 2026.